MTOR and melanoma: Furthermore, NPC-402 downregulated AKT survival signaling pathway (Figures 4K, L) albeit upregulated the expression of p-mTOR (Figure 4L), corroborating with growth inhibitory effects of NPC-402 in B16F10 melanoma cells.